Parkinson’s Disease Genes VPS35 and EIF4G1 Interact Genetically and Converge on Α-Synuclein

Neuron - United States
doi 10.1016/j.neuron.2014.11.027
Full Text
Abstract

Available in full text

Categories
Neuroscience
Date
Authors
Publisher

Elsevier BV

Related search

VPS35, the Retromer Complex and Parkinson’s Disease

Journal of Parkinson's Disease
Molecular NeuroscienceNeurologyCellular
2017English

Α-Synuclein: A Therapeutic Target for Parkinson’s Disease?

Pharmacological Research
Pharmacology
2008English

Α-Synuclein and Anti-Α-Synuclein Antibodies in Parkinson’s Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls

PLoS ONE
Multidisciplinary
2012English

Whole Exome Sequencing of Rare Variants in EIF4G1 and VPS35 in Parkinson Disease

Neurology
Neurology
2013English

Elevated Serum Α-Synuclein Autoantibodies in Patients With Parkinson’s Disease Relative to Alzheimer’s Disease and Controls

Frontiers in Neurology
Neurology
2017English

Lack of Pathogenic Potential of Peripheral Α-Synuclein Aggregates From Parkinson’s Disease Patients

Acta neuropathologica communications
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2018English

High Expression Levels of the D686N Parkinson's Disease Mutation in VPS35 Induces Α-Synuclein-Dependent Toxicity in Yeast

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

DJ-1 Interactions With Α-Synuclein Attenuate Aggregation and Cellular Toxicity in Models of Parkinson’s Disease

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2014English

Alpha-Synuclein Structure and Parkinson’s Disease – Lessons and Emerging Principles

Molecular Neurodegeneration
Molecular NeuroscienceNeurologyMolecular BiologyCellular
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy